Developer docs
API playgroundTry for free, no card

Search company profiles

Kent Imaging

Full company profile

uuid00007hp

Namestring
Kent Imaging
Legal namestring
Kent Imaging Inc.
Websiteurl
kentimaging.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Kent Imaging is a Calgary-based, privately held medical device company founded in 2006 that designs, manufactures, and markets multispectral imaging systems for tissue oxygenation and bacterial bioburden assessment. Its flagship product, SnapshotNIR, is a handheld near-infrared spectroscopy (NIRS) device that measures tissue oxygen saturation (StO2) and hemoglobin trends in microcirculation in under two seconds at the bedside, with a proprietary melanin-compensating algorithm enabling accurate measurement across diverse skin tones. Its second product, SnapshotGLO, launched in September 2025, provides portable fluorescence-based bacterial bioburden assessment. Together the two devices form the 'Snapshot Suite,' which the company markets as a dual-insight diagnostic workflow for chronic wounds, diabetic foot ulcers, pressure injuries, reconstructive surgery flap viability, and peripheral arterial disease screening.

The company operates a hybrid go-to-market model: direct field and inside sales in North America, paired with exclusive regional distributors internationally — MediMax Global in the UK and Ireland, PRHOINSA in Spain, R-Cure Medical in Israel, and Roots Pharmaceutical across Iraq and the Gulf Cooperation Council. Kent Imaging sells primarily to wound care specialists, limb preservation programs, vascular surgeons, and plastic/reconstructive surgeons through hospital and clinic procurement. Pricing is quote-based and not publicly disclosed, consistent with enterprise medical device sales. The company holds FDA 510(k) clearance (2017, updated to KD205 in 2024), CE Marking (September 2025), MHRA registration (2025), and Health Canada approval (December 2025), and has built EHR integrations with Epic, DocNow, WoundExpert, and CarePICS.

Kent Imaging is backed by TVM Life Science following a $15 million financing in February 2021, the largest disclosed funding round, alongside earlier capital from the Western Innovation (WINN) Initiative and founder Don Chapman. The company is led by CEO Pierre Lemire (joined 2015; previously founded Calgary Scientific) following the passing of founder Don Chapman in February 2025. A meaningful near-term overhang is the U.S. International Trade Commission investigation instituted January 28, 2026 against the SnapshotGLO product based on a MolecuLight complaint alleging infringement of U.S. Patent No. 10,438,356, which Kent Imaging is contesting.

Short descriptiontext

Kent Imaging designs and markets handheld near-infrared (SnapshotNIR) and fluorescence (SnapshotGLO) imaging devices that assess tissue oxygenation and bacterial bioburden for wound care, vascular, and reconstructive surgery clinicians, selling direct in North America and via exclusive regional distributors across Europe and the Middle East.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCalgary, Canada
HQ citystring
Calgary
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging devices, tissue oxygenation imaging, near-infrared spectroscopy, wound care diagnostics, fluorescence imaging
Industry3 codes
PRIMARYHLAHACAD
Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Devices
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales (SnapshotNIR and SnapshotGLO)
TypeHardware Sales
Description

Kent Imaging generates revenue from the sale of its near-infrared tissue oxygenation imaging devices. The company sells directly and through distribution partners internationally. Device pricing appears to be quote-based with consideration for healthcare facility procurement processes.

kentimaging.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Device purchase model - no public pricing disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Medical device pricing requires consultation with sales team. The company operates through a network of distributors internationally and direct sales domestically.

kentimaging.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1SnapshotNIR
Description

Near-infrared tissue oxygenation imaging device that measures oxygenated and deoxygenated hemoglobin to assess tissue viability in real time, designed for wound care, vascular, and surgical applications.

kentimaging.com
+2 more records
Core offering1 text field

Kent Imaging designs, manufactures, and markets near-infrared spectroscopy (NIRS) imaging devices, primarily the handheld SnapshotNIR device that measures tissue oxygen saturation (StO2) and hemoglobin trends in microcirculation, and the SnapshotGLO fluorescence imaging device for non-invasive bacterial bioburden detection at the bedside. These devices serve wound care, vascular disease assessment, and reconstructive surgery applications in healthcare facilities.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Kent Imaging offers two core diagnostic imaging products: SnapshotNIR and SnapshotGLO. SnapshotNIR is a handheld near-infrared spectroscopy device that measures tissue oxygen saturation (StO2) and viability, used in wound care, vascular screening, and reconstructive surgery. SnapshotGLO is a portable fluorescence imaging device for bacterial bioburden detection at point-of-care. Together they form the 'Snapshot Suite' providing dual imaging insights revealing two key barriers to healing: low tissue oxygenation and elevated bacterial bioburden.

Product and service2 records
1SnapshotNIR
CategoryMedical Imaging Device
Description

Handheld near-infrared spectroscopy device that measures oxygenated and deoxygenated hemoglobin to assess tissue oxygen saturation (StO2) and tissue viability in real time. Used for wound care, vascular disease screening, and surgical applications. Captures data in under 2 seconds at the bedside.

2SnapshotGLO
CategoryMedical Imaging Device
Description

Portable bacteria assessment device that non-invasively detects bacterial bioburden at the bedside using fluorescence imaging technology for point-of-care diagnostic imaging.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierKey RegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-13
Description

Kent Imaging appointed Roots Pharmaceutical as authorized distributor of SnapshotNIR across Iraq and the Gulf Cooperation Council countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE). The agreement brings non-invasive tissue oxygenation imaging technology to a region with high rates of diabetes and diabetic foot complications. Both companies will initially focus on wound care, vascular disease, and diabetes-related complications through Roots' established hospital and healthcare system relationships across more than ten markets in the MENA region.

Strategic tierKey RegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-03
Description

PRHOINSA serves as distribution partner for Kent Imaging's commercial launch of SnapshotNIR in Spain following CE Marking approval. The partnership represents a key milestone in Kent Imaging's European expansion strategy, enabling local market access for the near-infrared tissue oxygenation device.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-02-19
Description

New Horizon Medical Solutions is identified as a partnership supporting Kent Imaging's positioning for expanded global reach, working alongside TVM Life Science backing.

Strategic tierKey RegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-10
Description

MediMax Global appointed as exclusive distributor for Kent Imaging's SnapshotNIR tissue oxygenation imaging device in the UK and Eire. The partnership aims to expand access to this medical technology supporting clinicians in wound care management by providing rapid tissue health assessments.

Strategic tierKey RegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-20
Description

R-Cure Medical in Israel received authorization to distribute Kent Imaging's updated SnapshotNIR KD205 device, which measures tissue oxygenation and viability. The product is particularly used in breast reconstruction surgery and wound care, with emphasis on achieving better clinical outcomes and expanding accessibility in the Israeli market.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MolecuLight manufactures the i:X handheld fluorescence imaging device for real-time visualization of bacteria in wounds — directly competing with Kent's SnapshotGLO. MolecuLight is also the complainant in the active ITC patent investigation against Kent's SnapshotGLO product.

TypeDirect peer
Description

HyperMed Imaging produces HyperView, a hyperspectral imaging system that assesses tissue oxygenation and perfusion in wounds and tissue — directly comparable to Kent's SnapshotNIR in core technology (spectral tissue imaging) and clinical use case (wound care oxygenation assessment).

TypeDirect peer
Description

WoundVision offers the Snapshot (different brand) near-infrared spectroscopy imaging system for tissue oxygenation assessment in chronic wound management, directly competing with Kent's SnapshotNIR in the wound-care clinician market.

TypeDirect peer
Description

Spectros develops T-Stat and other NIRS-based tissue oximetry devices used in surgical and critical-care settings. Comparable to Kent Imaging in core NIRS tissue oxygenation measurement technology and clinical focus on perfusion and viability assessment.

TypeEmerging player
Description

Modulated Imaging developed the Clarifi Imaging System using spatial frequency domain imaging for tissue oxygenation and perfusion assessment, overlapping with Kent's SnapshotNIR in clinical application (perfusion imaging) while using a different imaging modality (SFDI vs NIRS).

TypeBroad incumbent
Description

Masimo is a global leader in pulse oximetry and patient monitoring technologies. While not a direct competitor in NIRS tissue imaging, Masimo's SET pulse oximetry platform competes for the same clinical budget and clinician workflow attention in oxygenation monitoring.

TypeBroad incumbent
Description

Medtronic offers the INVOS cerebral/somatic oximetry system using NIRS technology for tissue oxygenation monitoring in surgical and ICU settings. INVOS is an established competitor in the broader tissue oximetry category in which Kent Imaging operates.

TypeBroad incumbent
Description

Edwards Lifesciences provides FloTrac and other advanced patient monitoring solutions including tissue oximetry through acquired platforms. Edwards competes for hospital capital and monitoring-budget dollars relevant to Kent's perfusion and oxygenation monitoring use cases.

TypeBroad incumbent
Description

Nonin Medical is a long-established manufacturer of pulse oximeters and regional oximetry sensors. Comparable to Kent in oxygen-saturation monitoring technology, with overlapping clinical customers in wound care and vascular assessment.

TypeOthers
Description

Hamamatsu Photonics manufactures advanced photonic sensors, detectors, and imaging components used in medical and scientific imaging applications — an enabling supplier/ecosystem participant in the multispectral and NIR imaging category where Kent Imaging competes.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kent Imaging

Medical Imaging Deviceskentimaging.com

Kent Imaging designs and markets handheld near-infrared (SnapshotNIR) and fluorescence (SnapshotGLO) imaging devices that assess tissue oxygenation and bacterial bioburden for wound care, vascular, and reconstructive surgery clinicians, selling direct in North America and via exclusive regional distributors across Europe and the Middle East.

What Kent Imaging does

Kent Imaging is a Calgary-based, privately held medical device company founded in 2006 that designs, manufactures, and markets multispectral imaging systems for tissue oxygenation and bacterial bioburden assessment. Its flagship product, SnapshotNIR, is a handheld near-infrared spectroscopy (NIRS) device that measures tissue oxygen saturation (StO2) and hemoglobin trends in microcirculation in under two seconds at the bedside, with a proprietary melanin-compensating algorithm enabling accurate measurement across diverse skin tones. Its second product, SnapshotGLO, launched in September 2025, provides portable fluorescence-based bacterial bioburden assessment. Together the two devices form the 'Snapshot Suite,' which the company markets as a dual-insight diagnostic workflow for chronic wounds, diabetic foot ulcers, pressure injuries, reconstructive surgery flap viability, and peripheral arterial disease screening.

The company operates a hybrid go-to-market model: direct field and inside sales in North America, paired with exclusive regional distributors internationally — MediMax Global in the UK and Ireland, PRHOINSA in Spain, R-Cure Medical in Israel, and Roots Pharmaceutical across Iraq and the Gulf Cooperation Council. Kent Imaging sells primarily to wound care specialists, limb preservation programs, vascular surgeons, and plastic/reconstructive surgeons through hospital and clinic procurement. Pricing is quote-based and not publicly disclosed, consistent with enterprise medical device sales. The company holds FDA 510(k) clearance (2017, updated to KD205 in 2024), CE Marking (September 2025), MHRA registration (2025), and Health Canada approval (December 2025), and has built EHR integrations with Epic, DocNow, WoundExpert, and CarePICS.

Kent Imaging is backed by TVM Life Science following a $15 million financing in February 2021, the largest disclosed funding round, alongside earlier capital from the Western Innovation (WINN) Initiative and founder Don Chapman. The company is led by CEO Pierre Lemire (joined 2015; previously founded Calgary Scientific) following the passing of founder Don Chapman in February 2025. A meaningful near-term overhang is the U.S. International Trade Commission investigation instituted January 28, 2026 against the SnapshotGLO product based on a MolecuLight complaint alleging infringement of U.S. Patent No. 10,438,356, which Kent Imaging is contesting.

Kent Imaging firmographics

Firmographics
Name
Kent Imaging
Legal name
Kent Imaging Inc.
Website
https://kentimaging.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Kent Imaging designs and markets handheld near-infrared (SnapshotNIR) and fluorescence (SnapshotGLO) imaging devices that assess tissue oxygenation and bacterial bioburden for wound care, vascular, and reconstructive surgery clinicians, selling direct in North America and via exclusive regional distributors across Europe and the Middle East.
Ownership category
akta.pro rank

Kent Imaging industry classification

Industry
Product category
Medical Imaging Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAD
Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • Medical imaging devices
  • Tissue oxygenation imaging
  • Near-infrared spectroscopy
  • Wound care diagnostics
  • Fluorescence imaging

Where Kent Imaging is headquartered

Location

Headquarters

HQ city
Calgary
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Kent Imaging business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Device Sales (SnapshotNIR and SnapshotGLO): Kent Imaging generates revenue from the sale of its near-infrared tissue oxygenation imaging devices. The company sells directly and through distribution partners internationally. Device pricing appears to be quote-based with consideration for healthcare facility procurement processes.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractDevice purchase model - no public pricing disclosed

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Kent Imaging product offering

Product offering

Core offering

Kent Imaging designs, manufactures, and markets near-infrared spectroscopy (NIRS) imaging devices, primarily the handheld SnapshotNIR device that measures tissue oxygen saturation (StO2) and hemoglobin trends in microcirculation, and the SnapshotGLO fluorescence imaging device for non-invasive bacterial bioburden detection at the bedside. These devices serve wound care, vascular disease assessment, and reconstructive surgery applications in healthcare facilities.

Product overview

Kent Imaging offers two core diagnostic imaging products: SnapshotNIR and SnapshotGLO. SnapshotNIR is a handheld near-infrared spectroscopy device that measures tissue oxygen saturation (StO2) and viability, used in wound care, vascular screening, and reconstructive surgery. SnapshotGLO is a portable fluorescence imaging device for bacterial bioburden detection at point-of-care. Together they form the 'Snapshot Suite' providing dual imaging insights revealing two key barriers to healing: low tissue oxygenation and elevated bacterial bioburden.

Differentiator

Problem solved

Functional benefit

Brands

  • SnapshotNIR: Near-infrared tissue oxygenation imaging device that measures oxygenated and deoxygenated hemoglobin to assess tissue viability in real time, designed for wound care, vascular, and surgical applications.
  • SnapshotGLO
  • Snapshot Suite

Products and services

  • SnapshotNIR Handheld near-infrared spectroscopy device that measures oxygenated and deoxygenated hemoglobin to assess tissue oxygen saturation (StO2) and tissue viability in real time. Used for wound care, vascular disease screening, and surgical applications. Captures data in under 2 seconds at the bedside.
  • SnapshotGLO Portable bacteria assessment device that non-invasively detects bacterial bioburden at the bedside using fluorescence imaging technology for point-of-care diagnostic imaging.

Companies that use Kent Imaging

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Kent Imaging technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature5 records

Kent Imaging partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered key regional and strategic.

  • Roots Pharmaceutical Company W.L.L.key regionalChannel Partner/ Reseller/ Distributor · 13 May 2026Kent Imaging appointed Roots Pharmaceutical as authorized distributor of SnapshotNIR across Iraq and the Gulf Cooperation Council countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE). The agreement brings non-invasive tissue oxygenation imaging technology to a region with high rates of diabetes and diabetic foot complications. Both companies will initially focus on wound care, vascular disease, and diabetes-related complications through Roots' established hospital and healthcare system relationships across more than ten markets in the MENA region.
  • PRHOINSAkey regionalChannel Partner/ Reseller/ Distributor · 3 March 2026PRHOINSA serves as distribution partner for Kent Imaging's commercial launch of SnapshotNIR in Spain following CE Marking approval. The partnership represents a key milestone in Kent Imaging's European expansion strategy, enabling local market access for the near-infrared tissue oxygenation device.
  • New Horizon Medical SolutionsstrategicStrategic or Co-development Partner · 19 February 2026New Horizon Medical Solutions is identified as a partnership supporting Kent Imaging's positioning for expanded global reach, working alongside TVM Life Science backing.
  • MediMax Globalkey regionalChannel Partner/ Reseller/ Distributor · 10 November 2025MediMax Global appointed as exclusive distributor for Kent Imaging's SnapshotNIR tissue oxygenation imaging device in the UK and Eire. The partnership aims to expand access to this medical technology supporting clinicians in wound care management by providing rapid tissue health assessments.
  • R-Cure Medicalkey regionalChannel Partner/ Reseller/ Distributor · 20 October 2025R-Cure Medical in Israel received authorization to distribute Kent Imaging's updated SnapshotNIR KD205 device, which measures tissue oxygenation and viability. The product is particularly used in breast reconstruction surgery and wound care, with emphasis on achieving better clinical outcomes and expanding accessibility in the Israeli market.

Scale indicators4 records

Recent moves10 records

Expansion highlights5 records

Kent Imaging competitors and assessment

Company assessment

Direct peers

  • MolecuLight: MolecuLight manufactures the i:X handheld fluorescence imaging device for real-time visualization of bacteria in wounds — directly competing with Kent's SnapshotGLO. MolecuLight is also the complainant in the active ITC patent investigation against Kent's SnapshotGLO product.
  • HyperMed Imaging: HyperMed Imaging produces HyperView, a hyperspectral imaging system that assesses tissue oxygenation and perfusion in wounds and tissue — directly comparable to Kent's SnapshotNIR in core technology (spectral tissue imaging) and clinical use case (wound care oxygenation assessment).
  • WoundVision: WoundVision offers the Snapshot (different brand) near-infrared spectroscopy imaging system for tissue oxygenation assessment in chronic wound management, directly competing with Kent's SnapshotNIR in the wound-care clinician market.
  • Spectros Corporation: Spectros develops T-Stat and other NIRS-based tissue oximetry devices used in surgical and critical-care settings. Comparable to Kent Imaging in core NIRS tissue oxygenation measurement technology and clinical focus on perfusion and viability assessment.

Emerging players

  • Modulated Imaging: Modulated Imaging developed the Clarifi Imaging System using spatial frequency domain imaging for tissue oxygenation and perfusion assessment, overlapping with Kent's SnapshotNIR in clinical application (perfusion imaging) while using a different imaging modality (SFDI vs NIRS).

Broad incumbents

  • Masimo: Masimo is a global leader in pulse oximetry and patient monitoring technologies. While not a direct competitor in NIRS tissue imaging, Masimo's SET pulse oximetry platform competes for the same clinical budget and clinician workflow attention in oxygenation monitoring.
  • Medtronic: Medtronic offers the INVOS cerebral/somatic oximetry system using NIRS technology for tissue oxygenation monitoring in surgical and ICU settings. INVOS is an established competitor in the broader tissue oximetry category in which Kent Imaging operates.
  • Edwards Lifesciences: Edwards Lifesciences provides FloTrac and other advanced patient monitoring solutions including tissue oximetry through acquired platforms. Edwards competes for hospital capital and monitoring-budget dollars relevant to Kent's perfusion and oxygenation monitoring use cases.
  • Nonin Medical: Nonin Medical is a long-established manufacturer of pulse oximeters and regional oximetry sensors. Comparable to Kent in oxygen-saturation monitoring technology, with overlapping clinical customers in wound care and vascular assessment.

Others

  • Hamamatsu Photonics: Hamamatsu Photonics manufactures advanced photonic sensors, detectors, and imaging components used in medical and scientific imaging applications — an enabling supplier/ecosystem participant in the multispectral and NIR imaging category where Kent Imaging competes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Kent Imaging social profiles

Digital presence

Kent Imaging compliance and trust

Trust signal

Compliance4 records

Kent Imaging financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kent Imaging leadership team

Management profile

Number of profiles

Profiles11 records

Kent Imaging funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kent Imaging M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kent Imaging

What does Kent Imaging do?

Kent Imaging designs, manufactures, and markets near-infrared spectroscopy (NIRS) imaging devices, primarily the handheld SnapshotNIR device that measures tissue oxygen saturation (StO2) and hemoglobin trends in microcirculation, and the SnapshotGLO fluorescence imaging device for non-invasive bacterial bioburden detection at the bedside. These devices serve wound care, vascular disease assessment, and reconstructive surgery applications in healthcare facilities.

Is Kent Imaging a public or private company?

Kent Imaging is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kent Imaging founded?

Kent Imaging was founded in 2006. It employs 11 to 50 people.

Where is Kent Imaging based?

Kent Imaging is headquartered in Calgary, Canada, in the North America region.

How does Kent Imaging make money?

One revenue line is on record: medical Device Sales (SnapshotNIR and SnapshotGLO).

Who are Kent Imaging's main competitors?

Direct peers on record are MolecuLight, HyperMed Imaging, WoundVision and Spectros Corporation. Modulated Imaging is listed as an emerging player. Broad incumbents are Masimo, Medtronic, Edwards Lifesciences and Nonin Medical. Hamamatsu Photonics is listed as an others.

Does Kent Imaging have an API?

No public API is recorded for Kent Imaging.

What industry is Kent Imaging in?

Kent Imaging's product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry), with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialKent Imaging Partners With IPCIUM To Bring Snapshotnir Tissue Oxygenation Imaging To Aged Care: Australia & New ZealandKent Imaging and IPCIUM announced an exclusive partnership to bring SnapshotNIR tissue oxygenation imaging to aged care providers in Australia and New Zealand. IPCIUM becomes the exclusive distributor, integrating the device into its care platform to enable earlier wound detection and reduce complications. Providers can contact IPCIUM to arrange a demonstration.EIN PresswireKent Imaging partners with IPCIUM to bring SnapshotNIR tissue oxygenation imaging to aged care: Australia & New ZealandKent Imaging and IPCIUM announced an exclusive partnership to bring SnapshotNIR tissue oxygenation imaging to aged care providers in Australia and New Zealand. IPCIUM becomes the exclusive distributor, integrating the device into its care platform to enable earlier wound detection and reduce complications. Aged care providers can contact IPCIUM to arrange a demonstration.EIN PresswireKent Imaging Partners with EmeraNova to Expand Access to Advanced Wound ImagingKent Imaging announced a partnership with EmeraNova, the new corporate identity of BioLab Holdings, to integrate its SnapshotNIR and SnapshotGLO wound imaging devices into EmeraNova's tissue restoration toolbox. The collaboration aims to expand access to advanced wound imaging across care settings, with EmeraNova's network accelerating adoption in the United States.Financial PostEmeraNova™ Expands Access to Wound Imaging, Supporting Clinical Diagnostic CapabilitiesEmeraNova announced a collaboration with Kent Imaging to bring wound imaging to wound care clinics, surgical centers, hospitals, and HOPDs. The partnership combines SnapshotNIR for tissue oxygenation and SnapshotGLO for bacterial bioburden detection, aiming to expand diagnostic capabilities across care settings.Business Wire BlogEmeraNova™ Expands Access to Wound Imaging, Supporting Clinical Diagnostic CapabilitiesEmeraNova announced a collaboration with Kent Imaging to bring wound imaging to clinics and hospitals. The partnership adds SnapshotNIR and SnapshotGLO devices to detect low tissue oxygenation and elevated bacterial bioburden. EmeraNova will support broader adoption through its commercialization network.EIN PresswireKent Imaging Partners with TrueGraft to Integrate Precision Wound Sizing into the Snapshot Imaging PlatformKent Imaging announced a partnership with TrueGraft to integrate wound measurement and graft sizing into its Snapshot platform. The collaboration combines TrueGraft's calibrated sizing with SnapshotNIR's tissue oxygenation and SnapshotGLO's bacterial imaging. The unified platform aims to provide objective records for advanced wound care modalities.24-7 Press ReleaseWomen in Wound Care (WIWC) Launches First Nonprofit Community to Elevate Women in Wound Care ScienceWomen in Wound Care launched its first nonprofit community at the 2026 SAWC to elevate women in wound care science. The 501(c)(3) foundation, founded in 2026 by Dawn Shepherd, Dr. Cyaandi Dove, and Dr. Christine Grogan, seeks funding for education and mentorship. Nova Medical and Kent Imaging have supported it.FinancialContent Business PageWomen in Wound Care (WIWC) Launches First Nonprofit Community to Elevate Women in Wound Care ScienceWomen in Wound Care launched a nonprofit at the 2026 SAWC to elevate women in wound care science. The 501(c)(3) foundation, founded in 2026 by Dawn Shepherd, Dr. Cyaandi Dove, and Dr. Christine Grogan, seeks funding for education and mentorship. Nova Medical and Kent Imaging have supported it.EIN PresswireKent Imaging Partners with Marathon Medical Expanding Wound Imaging Across the U.S. Department of Veterans AffairsKent Imaging and Marathon Medical announced a partnership to expand wound imaging across U.S. Department of Veterans Affairs facilities. The collaboration combines Kent's SnapshotNIR and SnapshotGLO devices with Marathon's 20-year federal healthcare distribution experience. The partnership aims to improve wound care outcomes and reduce preventable amputations among Veterans.EIN PresswireKent Imaging Advances SnapshotNIR with Epic EHR Integration and Enhanced Clinical WorkflowsKent Imaging released a software update to SnapshotNIR featuring Epic EHR integration and enhancements from clinician feedback. The update lets clinicians document near-infrared images directly into Epic records, reducing documentation burden. The company plans to expand deployment across Tanner Health locations.